Filtros de búsqueda

Lista de obras de Biagio De Angelis

ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism

artículo científico publicado en 2021

Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma

artículo científico publicado en 2018

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

artículo científico publicado en 2017

CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells

artículo científico publicado en 2020

Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma.

artículo científico publicado en 2018

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

artículo científico publicado en 2008

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

artículo científico publicado en 2019

Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor

artículo científico publicado en 2018

Gene therapy to improve migration of T cells to the tumor site.

artículo científico publicado en 2010

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

artículo científico publicado en 2009

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

artículo científico publicado en 2011

Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing

artículo científico publicado en 2019

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate

artículo científico publicado en 2007

Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma

artículo científico publicado en 2012

MB-64ADOPTIVE CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA BASED ON T CELLS REDIRECTED TOWARD TUMOR CELLS BY PRAME SPECIFIC αβTCR GENE MODIFICATION.

artículo científico publicado en 2016

Overcoming Challenges in CAR T-cell Product CGMP Release.

artículo científico publicado en 2016

Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia

artículo científico publicado en 2013

Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours

scientific article published on 01 March 2020

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

artículo científico publicado en 2009

Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling

artículo científico publicado en 2021

Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma

artículo científico publicado en 2019

Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells

scientific article published on 22 November 2019

WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene

artículo científico publicado en 2015

Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda